In addition, the protein also affects the activity of key signaling pathways, such as NF-κB and Keap1/Nrf2/HO-1, further alleviating IBD symptoms by inhibiting inflammatory responses and enhancing antioxidant capacity (Figure 1). The gene discussed is HMOX1; the disease is inflammatory bowel disease.